Trends in Length of Stay and Readmissions in Children’s Hospitals

2021 ◽  
Vol 11 (6) ◽  
pp. 554-562
Author(s):  
Charlotte M. Brown ◽  
Derek J. Williams ◽  
Matt Hall ◽  
Katherine L. Freundlich ◽  
David P. Johnson ◽  
...  
2012 ◽  
Vol 60 (3) ◽  
pp. 415-419 ◽  
Author(s):  
Anthony N. Audino ◽  
Nicholas D. Yeager ◽  
Lindsey Asti ◽  
Yongjie Miao ◽  
Sarah H. O'Brien

2019 ◽  
Vol 14 (2) ◽  
pp. 75-82
Author(s):  
Jessica L Markham ◽  
Troy Richardson ◽  
Matthew Hall ◽  
Christopher P. Bonafide ◽  
Derek J. Williams ◽  
...  

2020 ◽  
Vol 15 (7) ◽  
pp. 403-406
Author(s):  
Vineeta Mittal ◽  
Matt Hall ◽  
James Antoon ◽  
Jessica Gold ◽  
Chen Kenyon ◽  
...  

Intravenous (IV) magnesium is used as an adjunct therapy in management of status asthmaticus with a goal of reducing intubation rate. A recent review suggests that IV magnesium use in status asthmaticus reduces admission rates. This is contrary to the observation of practicing emergency room physicians. The goal of this study was to assess trends in IV magnesium use for status asthmaticus in US children’s hospitals over 8 years through a retrospective analysis of children younger than 18 years using the Pediatric Health Information System database. Outcomes were IV magnesium use, inpatient and intensive care unit admission rate, geometric mean length of stay, and 7-day all-cause readmission rate. IV magnesium use for asthma hospitalization more than doubled over 8 years (17% vs. 36%; P < .001). Yearly trends were not significantly associated with hospital or intensive care unit admission rate or 7-day all-cause readmissions, although length of stay was reduced (P < .001).


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 1507-1507
Author(s):  
Amanda Dickerson ◽  
Jennifer Klima ◽  
Melissa Rhodes ◽  
Sarah H. O'Brien

Abstract Abstract 1507 Background: In recent decades, child mortality in sickle cell disease (SCD) has drastically decreased. Consequently, there is a growing population of young adults with SCD. The period of transition from pediatric to adult care is a vulnerable time for patients with chronic disease, and patients with conditions such as cystic fibrosis and congenital heart disease may continue care in pediatric settings well into young adulthood. To explore the impact of transitioning SCD patients at 18 years versus 21 years on children's hospitals, we compared reasons for hospitalization and resulting charges in adolescents (13-17 years) and young adults (18-21 years) admitted from 2000-09. Methods: Data were obtained from 25 children's hospitals within the Pediatric Health Information System (PHIS), a large administrative database of freestanding children's hospitals. SCD patients were identified by ICD-9-CM primary or secondary diagnostic codes of 282.41-42 or 282.60-69. Demographics, length of stay, discharge status, principal payer, diagnoses, procedures, and charges were compared between age groups. Length of stay and charges were not normally distributed and therefore were analyzed using the Wilcoxon rank sum test. Categorical data were compared using chi square statistics. Results: We identified 25,371 admissions of adolescents (n=18,299) and young adults (n=7,072) with SCD from 2000-09, with young adults accounting for 28% of admissions. These admissions represent 4,247 unique patients (52% female) with a range of 1 to 119 admissions per patient (median=3). We identified substantial variety in age of transition to adult care among participating hospitals. Using the 90th percentile (p90) of patient age as a surrogate for transition, we identified the following ages of transition: 18 years (n=2 hospitals), 19 years (n=5), 20 years (n=11), 21 years (n=6), and 22 years (n=1). Reasons for hospitalization were similar between the two age groups, with no clinically significant differences in the frequency of common discharge diagnoses or procedures (Table). Young adults were not more likely to be transferred to other facilities for additional care. Complications of adult SCD such as nephropathy and pulmonary hypertension were rare, occurring in <2.5% of discharges. Although length of stay was similar between adolescents and young adults (median=4 days), young adults tended to incur higher charges (median +$1,314, p<0.001) and were more likely to be covered by public insurance. Deaths (0.2% of admissions) were notably rare and similar across age groups (p=0.7). Discussion: Current practice patterns of U.S. children's hospitals vary with regard to age of transition to adult care for patients with SCD. Although our study was limited to those patients cared for in children's hospitals, adolescents (13-17 years) and young adults (18-21 years) with SCD appear to be quite similar with regards to reasons for hospitalization, and mortality was extremely low in both cohorts. Further studies are needed to investigate whether extending the age of transition to 21 years as a national standard may decrease morbidity, improve health-related quality of life, and increase readiness for transition in young patients with SCD. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 341-341
Author(s):  
Courtney Kime ◽  
Jennifer Klima ◽  
Sarah O'Brien

Abstract Abstract 341 Background: A state of equipoise exists in the pediatric hematology community regarding the management of acute immune thrombocytopenic purpura (ITP). While studies have established that ITP treatment raises platelet counts, there is no evidence that treatment prevents serious hemorrhage. Recent guidelines from both an international expert panel and the American Society of Hematology recommend that children with no or mild bleeding be managed with observation alone, and hospitalization be reserved for those with clinically significant bleeding. There are no published data regarding current patterns of inpatient care for pediatric ITP, and the impact of guidelines on clinical practice cannot be determined unless a baseline is established. The objective of this study was to better understand current national practice patterns for acute ITP in United States children's hospitals and investigate regional differences in care. Methods: We examined data from the Pediatric Health Information System, a proprietary database containing clinical and financial data from 43 U.S. children's hospital. Hospitals were divided into regions based on U.S. Census divisions. Data were extracted for all inpatients with ITP (ICD-9 code 287.31) aged 1–18 years discharged in 2008–2010. As our aim was to describe practice patterns for newly diagnosed acute ITP, patients were excluded if they had an ITP-related admission within six months prior to the study period. In patients with multiple ITP admissions during the study period, only the first admission was analyzed. To minimize the number of patients with thrombocytopenia due to other causes (ITP coding errors), we excluded those with other diagnoses associated with thrombocytopenia, such as cancer and lupus. We compared treatment strategies, length of stay, readmissions within 60 days, and total charges by region. Statistical analyses included χ2 tests for categorical outcomes and Kruskal-Wallis tests for ordinal outcomes. Results: Between 2008 and 2010, we identified 2,314 unique patients meeting the study diagnosis of acute ITP (Table). Only 13.1% of patients had an ICD-9 code suggestive of significant bleeding, with epistaxis the most commonly reported symptom. Even in our hospitalized population, <1% of patients had a diagnosis code of intracranial hemorrhage. We identified significant variation (p<0.05) by geographic region in all examined parameters (treatment strategies, length of stay, hospital charges, and likelihood of readmission). In all geographic regions, IVIG was the most utilized treatment strategy. The use of IVIG as a solitary therapy ranged from 66.2% of patients in Pacific states to 85.0% of patients in the West North Central region (MN, MO, KS). Mean length of stay ranged from 1.0–2.0 days among regions, with mean total charges per admission ranging from $12,460 in the New England/Mid-Atlantic region to $21,623 in the West South Central region (AR, LA, TX). Pharmacy costs accounted for 50% of charges. Rates of readmission within 60 days of initial ITP admission ranged from 5.5%-14.4% of patients. Conclusions: This analysis of the Pediatric Health Information System identified geographic variability in the use of ITP therapies and costs of care for children hospitalized with acute ITP in U.S. children's hospitals. While our data source did not allow us to determine platelet count or indication for hospitalization, our results suggest that a large number of children admitted with ITP in recent years did not have clinically significant bleeding, and potentially could have been managed with outpatient observation. Future studies will be able to identify if the number of ITP admissions, costs of care, and geographic variability in care decrease with the dissemination and implementation of recently published clinical guidelines. Disclosures: No relevant conflicts of interest to declare.


2013 ◽  
Vol 5 (1) ◽  
pp. 81-87 ◽  
Author(s):  
Vineeta Mittal ◽  
Evelina Krieger ◽  
Benjamin C. Lee ◽  
Terry Kind ◽  
Timothy McCavit ◽  
...  

Abstract Background Many academic hospitals have incorporated family-centered rounds, yet little is known about pediatrics residents' perspectives on the educational impact of these rounds. Objective To identify pediatrics residents' knowledge, attitudes, and beliefs about family-centered rounds, including perceived benefits and barriers. Methods We conducted focus groups of residents exposed to family-centered rounds at 2 university-affiliated, freestanding children's hospitals. Focus group data were analyzed using grounded theory. Results A total of 24 residents participated in 4 focus groups. Residents reported that family-centered rounds enhance education by increasing patient encounters and improving physical exam skills, direct observation, real-time feedback, and attending role modeling; improve parent satisfaction, interpersonal and communication skills, and safety; and reduce length of stay. Physical constraints (large teams and small rooms), lack of uniform approaches to family-centered rounds, variable attending teaching styles, and specific conditions (child abuse, patients on isolation) were cited barriers. Conclusions Pediatrics residents report that well-conducted family-centered rounds improve their education and the quality of patient care, including parent satisfaction, communication with families, and patients' length of stay. Standardizing family-centered rounds and reducing attending variability in teaching style might further enhance residents' educational experiences.


Author(s):  
Yao Tian ◽  
Matt Hall ◽  
Martha-Conley E Ingram ◽  
Andrew Hu ◽  
Mehul V Raval

BACKGROUND: Observation status could improve efficiency of healthcare resource use but also might shift financial burdens to patients and hospitals. Although the use of observation stays has increased for adult patient populations, the trends are unknown among hospitalized children. OBJECTIVE: The goal of this study was to describe recent trends in observation stays for pediatric populations at children’s hospitals. DESIGN, SETTING, AND PARTICIPANTS: Both observation and inpatient stays for all conditions were retrospectively studied using the Pediatric Health Information System database (2010 to 2019). EXPOSURE, MAIN OUTCOMES, AND MEASURES: Patient type was classified as inpatient or observation status. Main outcomes included annual percentage of observation stays, annual percentage of observation stays having prolonged length of stay (>2 days), and growth rates of observation stays for the 20 most common conditions. Risk adjusted hospital-level use of observation stays was estimated using generalized linear mixed-effects models. RESULTS: The percentage of observation stays increased from 23.6% in 2010 to 34.3% in 2019 (P < .001), and the percentage of observation stays with prolonged length of stay rose from 1.1% to 4.6% (P < .001). Observation status was expanded among a diverse group of clinical conditions; diabetes mellitus and surgical procedures showed the highest growth rates. Adjusted hospital-level use ranged from 0% to 67% in 2019, indicating considerable variation among hospitals. CONCLUSION: Based on the increase in observation stays, future studies should explore the appropriateness of observation care related to efficient use of healthcare resources and financial implications for hospitals and patients.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 3811-3811
Author(s):  
Meghan McCormick ◽  
James Zullo ◽  
Ram Kalpatthi

Abstract Introduction: Transfusion of blood products can be associated with a wide variety of complications ranging in level of severity. The most lethal of these are Transfusion-Associated Circulatory Overload (TACO) and Transfusion-Related Acute Lung injury (TRALI). Over the five year period from 2012-2016, TRALI was the leading cause of transfusion-associated fatalities, closely followed by TACO. However, the incidence of these potentially lethal transfusion reactions in the pediatric population is not well known. Our objective is to describe the incidence of these transfusion reactions in pediatric patients and describe their associated morbidity and mortality. Materials/Methods: We used the Pediatric Health Information System (PHIS), an electronic database of children's hospitals in the USA. Data was obtained from 45 children's hospitals in 2005-2015 for patients ≤ 21 years of age who received transfusion of packed red blood cells, platelets, whole blood, coagulation factors, other serum and exchange transfusion. From this group of patients, we then identified patients who developed TRALI and TACO. Patients were identified by ICD9 codes for transfusion of various blood products and related adverse events. We abstracted data on demographics, medication use, length of stay (LOS), hospital charges and mortality. Results: During the study period, 383,154 inpatient encounters in which patients received a blood product transfusion were identified. Overall the number of blood product transfusions has remained stable (Figure 1). There were 982 transfusion reactions per 100,000 hospital encounters over this period and the incidence rates of each type of transfusion reaction are described in Table 1. In our patient cohort, 108 cases of TRALI and 102 cases of TACO were identified. Cohorts were similar with regards to gender distribution. Distributions of age and race differed between the TRALI and TACO cohorts compared to the all transfusions cohort (Table 2). The morbidity, mortality and hospital charges of encounters complicated by TRALI and TACO are described in Table 3. In the TRALI cohort, a significantly greater number of patients required mechanical ventilation, ECMO or transfer to the ICU and had a greater increase in mortality in comparison to the all transfusion cohort. The TACO cohort had a significantly increased number of patients who required ECMO or ICU transfer compared to the all transfusions cohort. Length of stay was significantly greater for patients in the TRALI cohort compared to the all transfusions cohort. Patients diagnosed with either TRALI or TACO had significantly increased costs associated with hospitalization. Conclusion: Our study demonstrated that both TRALI and TACO are associated with an excess morbidity and mortality. However, the number of cases of TRALI and TACO in our study were fewer than what was expected based on previous studies. This indicates that TRALI and TACO are likely under-diagnosed and under-reported. Efforts should be made to increase awareness of recognizing and reporting of these transfusion reactions to improve the outcome of these potentially lethal complications. Disclosures No relevant conflicts of interest to declare.


PEDIATRICS ◽  
2020 ◽  
Vol 146 (5) ◽  
pp. e20200120
Author(s):  
James C. Gay ◽  
Matt Hall ◽  
Rustin Morse ◽  
Evan S. Fieldston ◽  
David Synhorst ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document